ASEPSIS-PACK
Dead / Cancelled — Cancelled — Section 8 (as of 05 Jul 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85530264
- Registration number
- 4255272
- Mark type
- Stylized text
- Filed
- 31 Jan 2012
- Published for opposition
- 15 May 2012
- Registered
- 04 Dec 2012
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes
Owner
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
Prosecution history
- 05 Jul 2019 — CANCELLED SEC. 8 (6-YR)
- 30 Apr 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Dec 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Dec 2012 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 09 Oct 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Oct 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Oct 2012 — USE AMENDMENT FILED
- 02 Oct 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Oct 2012 — TEAS STATEMENT OF USE RECEIVED
- 10 Jul 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 May 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 May 2012 — PUBLISHED FOR OPPOSITION
- 25 Apr 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED